Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

Condition:   Metastatic Anaplastic Thyroid Cancer
Interventions:   Drug: durvalumab;   Drug: tremelimumab;   Radiation: Stereotactic Body Radiotherapy (SBRT)
Sponsors:   Memorial Sloan Kettering Cancer Center;   AstraZeneca
Not yet recruiting - verified April 2017

http://ift.tt/2oP1As5